Stay updated on Alvocidib Biomarker AML Phase 2 Clinical Trial

Sign up to get notified when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alvocidib Biomarker AML Phase 2 Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-12-01T16:56:07.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page revision was updated from v3.2.0 to v3.3.1; no substantive changes to the study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T11:59:29.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The funding-status notice banner was removed from the page, leaving the study details displayed without that notice.
    Difference
    0.3%
    Check dated 2025-11-17T06:18:21.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No meaningful additions or deletions were detected between the screenshots; the page continues to present the study overview, eligibility criteria, and locations as before.
    Difference
    0.3%
    Check dated 2025-11-03T00:53:15.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    3%
    Check dated 2025-10-05T08:04:49.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T02:57:55.000Z thumbnail image

Stay in the know with updates to Alvocidib Biomarker AML Phase 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.